Assessing fall risk and preventing falls in the elderly

peer reviewedAssessment of fall risk in the elderly is clearly documented in the literature. However, intervention preventive strategies are not well identified. Two types of methods can be discussed: on the one hand, classical techniques using different tests and exercises in balance with materials and/or sensitization by dual task; on the other hand, rhythmic exercises. Their results and value are not quite established and further studies are needed to assess their prospective benefit, even if they seem interesting in some Parkinson's population. Physical activity and global fall management allow a better outcome in different gait parameters of the elderly

Thanasimus formicarius (Coleoptera: Cleridae) : Why a Large Range of Prey for a Specialized Predator ?

Abstract -Thanasimus formicarius (L.) (Coleoptera : Cleridae) is a generalist predator of many scolytid species in spruce, pine and broadleaf stands. We tested here the hypothesis that, having a protracted adult life, the predators must leave pine stands, most favourable for their development and forage in other types of forest stands to find suitable prey during their whole flight period. The results reported here (data from continuous passive trapping of pine, spruce and broad-leaf bark beetles), showed continuous presence of bark beetles in the pine stand, which would allow the predators to remain in pine stands during their whole life. However, we observed changes in species composition and abundance during our two-year experiment, suggesting that uncertainties in prey supply could explain T. formicarius' wider range of prey

Thanasimus formicarius (Coleoptera : Cleridae) : Why a Large Range of Prey for a Specialized Predator ?

Free University of BrusselsProceedings : IUFRO Kanazawa 2003 "Forest Insect Population Dynamics and Host Influences"., Scedule:14－19 September 2003, Vemue: Kanazawa Citymonde Hotel, Kanazawa, Japan, Joint metting of IUFRO working groups : 7.01.02 Tree resistance to Insects | 7.03.06 Integrated management of forset defoloating insects | 7.03.07 Population dynamics of forest insects, Sponsored by: IUFRO-J | Ishikawa Prefecture | Kanazawa City | 21st-COE Program of Kanazawa University, Editors: Kamata, Naoto | Liebhold, Nadrew M. | Quiring, Dan T. | Clancy, Karen M

Neuropsychological analysis of gait disturbances during dual task in MCI patients

peer reviewedaudience: researcher, professional, studen

A new free-surface stabilization algorithm for geodynamical modelling:Theory and numerical tests

The surface of the solid Earth is effectively stress free in its subaerial portions, and hydrostatic beneath the oceans. Unfortunately, this type of boundary condition is difficult to treat computationally, and for computational convenience, numerical models have often used simpler approximations that do not involve a normal stress-loaded, shear-stress free top surface that is free to move. Viscous flow models with a computational free surface typically confront stability problems when the time step is bigger than the viscous relaxation time. The small time step required for stability (<2. Kyr) makes this type of model computationally intensive, so there remains a need to develop strategies that mitigate the stability problem by making larger (at least ~10 Kyr) time steps stable and accurate. Here we present a new free-surface stabilization algorithm for finite element codes which solves the stability problem by adding to the Stokes formulation an intrinsic penalization term equivalent to a portion of the future load at the surface nodes. Our algorithm is straightforward to implement and can be used with both Eulerian or Lagrangian grids. It includes α and β parameters to respectively control both the vertical and the horizontal slope-dependent penalization terms, and uses Uzawa-like iterations to solve the resulting system at a cost comparable to a non-stress free surface formulation. Four tests were carried out in order to study the accuracy and the stability of the algorithm: (1) a decaying first-order sinusoidal topography test, (2) a decaying high-order sinusoidal topography test, (3) a Rayleigh-Taylor instability test, and (4) a steep-slope test. For these tests, we investigate which α and β parameters give the best results in terms of both accuracy and stability. We also compare the accuracy and the stability of our algorithm with a similar implicit approach recently developed by Kaus et al. (2010). We find that our algorithm is slightly more accurate and stable for steep slopes, and also conclude that, for longer time steps, the optimal α controlling factor for both approaches is ~2/3, instead of the 1/2 Crank-Nicolson parameter inferred from a linearized accuracy analysis. This more-implicit value coincides with the velocity factor for a Galerkin time discretization applied to our penalization term using linear shape functions in time

Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort

BACKGROUND: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized GUARD-C cohort investigated baseline predictors of safety-related dose reductions or discontinuations (sr-RD) and their impact on sustained virologic response (SVR) in patients receiving peginterferon alfa/ribavirin in routine practice. METHODS: A total of 3181 HCV-mono-infected treatment-naive patients were assigned to 24 or 48 weeks of peginterferon alfa/ribavirin by their physician. Patients were categorized by time-to-first sr-RD (Week 4/12). Detailed analyses of the impact of sr-RD on SVR24 (HCV RNA <50 IU/mL) were conducted in 951 Caucasian, noncirrhotic genotype (G)1 patients assigned to peginterferon alfa-2a/ribavirin for 48 weeks. The probability of SVR24 was identified by a baseline scoring system (range: 0-9 points) on which scores of 5 to 9 and <5 represent high and low probability of SVR24, respectively. RESULTS: SVR24 rates were 46.1% (754/1634), 77.1% (279/362), 68.0% (514/756), and 51.3% (203/396), respectively, in G1, 2, 3, and 4 patients. Overall, 16.9% and 21.8% patients experienced 651 sr-RD for peginterferon alfa and ribavirin, respectively. Among Caucasian noncirrhotic G1 patients: female sex, lower body mass index, pre-existing cardiovascular/pulmonary disease, and low hematological indices were prognostic factors of sr-RD; SVR24 was lower in patients with 651 vs. no sr-RD by Week 4 (37.9% vs. 54.4%; P = 0.0046) and Week 12 (41.7% vs. 55.3%; P = 0.0016); sr-RD by Week 4/12 significantly reduced SVR24 in patients with scores <5 but not 655. CONCLUSIONS: In conclusion, sr-RD to peginterferon alfa-2a/ribavirin significantly impacts on SVR24 rates in treatment-naive G1 noncirrhotic Caucasian patients. Baseline characteristics can help select patients with a high probability of SVR24 and a low probability of sr-RD with peginterferon alfa-2a/ribavirin

Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.

BACKGROUND: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized GUARD-C cohort investigated baseline predictors of safety-related dose reductions or discontinuations (sr-RD) and their impact on sustained virologic response (SVR) in patients receiving peginterferon alfa/ribavirin in routine practice. METHODS: A total of 3181 HCV-mono-infected treatment-naive patients were assigned to 24 or 48 weeks of peginterferon alfa/ribavirin by their physician. Patients were categorized by time-to-first sr-RD (Week 4/12). Detailed analyses of the impact of sr-RD on SVR24 (HCV RNA <50 IU/mL) were conducted in 951 Caucasian, noncirrhotic genotype (G)1 patients assigned to peginterferon alfa-2a/ribavirin for 48 weeks. The probability of SVR24 was identified by a baseline scoring system (range: 0-9 points) on which scores of 5 to 9 and <5 represent high and low probability of SVR24, respectively. RESULTS: SVR24 rates were 46.1% (754/1634), 77.1% (279/362), 68.0% (514/756), and 51.3% (203/396), respectively, in G1, 2, 3, and 4 patients. Overall, 16.9% and 21.8% patients experienced ≥1 sr-RD for peginterferon alfa and ribavirin, respectively. Among Caucasian noncirrhotic G1 patients: female sex, lower body mass index, pre-existing cardiovascular/pulmonary disease, and low hematological indices were prognostic factors of sr-RD; SVR24 was lower in patients with ≥1 vs. no sr-RD by Week 4 (37.9% vs. 54.4%; P = 0.0046) and Week 12 (41.7% vs. 55.3%; P = 0.0016); sr-RD by Week 4/12 significantly reduced SVR24 in patients with scores <5 but not ≥5. CONCLUSIONS: In conclusion, sr-RD to peginterferon alfa-2a/ribavirin significantly impacts on SVR24 rates in treatment-naive G1 noncirrhotic Caucasian patients. Baseline characteristics can help select patients with a high probability of SVR24 and a low probability of sr-RD with peginterferon alfa-2a/ribavirin.This study was sponsored by F. Hoffmann-La Roche Ltd, Basel, Switzerland. Support for third-party writing assistance for this manuscript, furnished by Blair Jarvis MSc, ELS, of Health Interactions, was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland